Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioids
1.0.0-ballot - STU 1 - Ballot United States of America flag

This page is part of the Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioids (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. No current official version has been published yet. For a full list of available versions, see the Directory of published versions

Table of Contents

Page standards status: Informative
.. 0 Table of Contents
... 1 Home
... 2 Background
... 3 Profiles
... 4 Terminology
... 5 Artifacts Summary
.... 5.1 Active Cancer Encounter Diagnosis Condition Profile
.... 5.2 Active Cancer Problem List Health Concern Condition Profile
.... 5.3 Acute Pain Management MedicationRequest Profile
.... 5.4 Amphetamine Medication Profile
.... 5.5 Amphetamine MedicationRequest Profile
.... 5.6 Amphetamine Urine Drug Screening Result Observation Profile
.... 5.7 Barbiturate Medication Profile
.... 5.8 Barbiturate MedicationRequest Profile
.... 5.9 Barbiturate Urine Drug Screening Result Observation Profile
.... 5.10 Benzodiazepine Medication Profile
.... 5.11 Benzodiazepine MedicationRequest Profile
.... 5.12 Benzodiazepine Urine Drug Screening Result Observation Profile
.... 5.13 Buprenorphine Medication Profile
.... 5.14 Buprenorphine MedicationRequest Profile
.... 5.15 Buprenorphine Urine Drug Screening Result Observation Profile
.... 5.16 Cannabinoid Urine Drug Screening Result Observation Profile
.... 5.17 Chronic Pain Management MedicationRequest Profile
.... 5.18 CNS Depressant Medication Profile
.... 5.19 CNS Depressant MedicationRequest Profile
.... 5.20 Cocaine Urine Drug Screening Result Observation Profile
.... 5.21 End of Life Encounter Diagnosis Profile
.... 5.22 End of Life Problem List Health Concern Condition Profile
.... 5.23 Extended Release Opioid Medication Profile
.... 5.24 Extended Release Opioid MedicationRequest Profile
.... 5.25 Fentanyl Medication Profile
.... 5.26 Fentanyl MedicationRequest Profile
.... 5.27 Fentanyl Urine Drug Screening Result Observation Profile
.... 5.28 Heroin Urine Drug Screening Result Observation Profile
.... 5.29 Methadone Medication Profile
.... 5.30 Methadone MedicationRequest Profile
.... 5.31 Methadone Urine Drug Screening Result Observation Profile
.... 5.32 MME MedicationRequest Profile
.... 5.33 Naloxone Medication Profile
.... 5.34 Naloxone MedicationRequest Profile
.... 5.35 Opiate Medication Profile
.... 5.36 Opiate MedicationRequest Profile
.... 5.37 Opiate Urine Drug Screening Result Observation Profile
.... 5.38 Opioid Medication Profile
.... 5.39 Opioid MedicationRequest Profile
.... 5.40 Opioid Misuse Assessment Procedure Profile
.... 5.41 Opioid Review Useful Patient Encounter Encounter Profile
.... 5.42 Opioid Review Useful Patient MedicationRequest Profile
.... 5.43 Opioid Review Useful Patient Profile
.... 5.44 Oxycodone Medication Profile
.... 5.45 Oxycodone MedicationRequest Profile
.... 5.46 Oxycodone Urine Drug Screening Result Observation Profile
.... 5.47 Pain Management Procedure Profile
.... 5.48 Pain Treatment CarePlan Profile
.... 5.49 PCP Urine Drug Screening Result Observation Profile
.... 5.50 PDMP Review Observation Profile
.... 5.51 PDMP Review Procedure Profile
.... 5.52 Sickle Cell Encounter Diagnosis Condition Profile
.... 5.53 Sickle Cell Problem List Health Concern Condition Profile
.... 5.54 Subacute or Chronic Pain Management MedicationRequest Profile
.... 5.55 Subacute Pain Management MedicationRequest Profile
.... 5.56 Urine Drug Screening Result Observation Profile
.... 5.57 Amphetamine class medications
.... 5.58 Amphetamine-class drugs and metabolite urine tests
.... 5.59 Barbiturate Medications
.... 5.60 Barbiturate urine drug screening tests
.... 5.61 Benzodiazepine medications
.... 5.62 Benzodiazepine urine drug screening tests
.... 5.63 Buprenorphine Medications
.... 5.64 Buprenorphine urine drug screening tests
.... 5.65 Cannabinoid class urine drug screening
.... 5.66 CDC malignant cancer conditions
.... 5.67 CNS depressant medications
.... 5.68 Cocaine urine drug screening tests
.... 5.69 Conditions likely terminal for opioid prescribing
.... 5.70 Extended release opioid with ambulatory misuse potential
.... 5.71 Fentanyl-type medications
.... 5.72 Fentanyl-type urine drug screening tests
.... 5.73 General opiate urine drug screening tests
.... 5.74 Heroin urine drug screening tests
.... 5.75 Methadone medications
.... 5.76 Methadone urine drug screening tests
.... 5.77 Naloxone medications
.... 5.78 Non-synthetic opioid medications
.... 5.79 Opioid analgesics with ambulatory misuse potential
.... 5.80 Opioid misuse assessment procedure
.... 5.81 Oxycodone Medications
.... 5.82 Oxycodone urine drug screening tests
.... 5.83 Pain management procedure
.... 5.84 Pain treatment plan
.... 5.85 PDMP data reviewed finding
.... 5.86 PDMP review procedure
.... 5.87 Phencyclidine urine drug screening tests
.... 5.88 Sickle-cell diseases
.... 5.89 Active Cancer Diagnosis Condition Example
.... 5.90 Active Cancer Health Concern Condition Example
.... 5.91 Acute Pain Management MedicationRequest Example
.... 5.92 Amphetamine Medication Example
.... 5.93 Amphetamine MedicationRequest Example
.... 5.94 Amphetamine Urine Drug Screening Result Observation Example
.... 5.95 Barbiturate Medication Example
.... 5.96 Barbiturate MedicationRequest Example
.... 5.97 Barbiturate Urine Drug Screening Result Observation Example
.... 5.98 Benzodiazepine Medication Example
.... 5.99 Benzodiazepine MedicationRequest Example
.... 5.100 Benzodiazepine Urine Drug Screening Result Observation Example
.... 5.101 Buprenorphine Medication Example
.... 5.102 Buprenorphine MedicationRequest Example
.... 5.103 Buprenorphine Urine Drug Screening Result Observation Example
.... 5.104 Cannabinoid Urine Drug Screening Result Observation Example
.... 5.105 Central Nervous System Depressant Medication Example
.... 5.106 Central Nervous System Depressant MedicationRequest Example
.... 5.107 Chronic Pain Management MedicationRequest Example
.... 5.108 Cocaine Urine Drug Screening Result Observation Example
.... 5.109 End of Life Diagnosis Example
.... 5.110 End of Life Problem List Example
.... 5.111 Extended Release Opioid Medication Example
.... 5.112 Extended Release Opioid MedicationRequest Example
.... 5.113 Fentanyl Medication Example
.... 5.114 Fentanyl MedicationRequest Example
.... 5.115 Fentanyl Urine Drug Screening Result Observation Example
.... 5.116 Heroine Urine Drug Screening Result Observation Example
.... 5.117 Methadone Medication Example
.... 5.118 Methadone MedicationRequest Example
.... 5.119 Methadone Urine Drug Screening Result Observation Example
.... 5.120 Milligram Morphine Equivalence MedicationRequest Example
.... 5.121 Naloxone Medication Example
.... 5.122 Naloxone MedicationRequest Example
.... 5.123 Opiate Medication Example
.... 5.124 Opiate MedicationRequest Example
.... 5.125 Opiate Urine Drug Screening Result Observation Example
.... 5.126 Opioid Medication Example
.... 5.127 Opioid MedicationRequest Example
.... 5.128 Opioid Misuse Assessment Procedure Example
.... 5.129 Opioid Review Useful Patient Encounter Example
.... 5.130 Opioid Review Useful Patient Example
.... 5.131 Opioid Review Useful Patient MedicationRequest Example
.... 5.132 Oxycodone Medication Example
.... 5.133 Oxycodone MedicationRequest Example
.... 5.134 Oxycodone Urine Drug Screening Result Observation Example
.... 5.135 Pain Management Procedure Example
.... 5.136 Pain Treatment Careplan Example
.... 5.137 PDMP Review Observation Example
.... 5.138 PDMP Review Procedure Example
.... 5.139 Phencyclidine Urine Drug Screening Result Observation Example
.... 5.140 Sickle Cell Encounter Diagnosis Example
.... 5.141 Sickle Cell Problem List Example
.... 5.142 Subacute Pain Management MedicationRequest Example
.... 5.143 US Core Practitioner Example
.... 5.144 CDCOpioidCPG Manifest
... 6 Downloads
... 7 Changes